Israel Englander Ardelyx, Inc. Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$3.28 - $5.51 $171,216 - $287,622	52,200 New	52,200 $204,000
Q1 2023 May 15, 2023	SELL	$2.68 - $4.79 $404,680 - $723,290	-151,000 Reduced 60.16%	100,000 $479,000
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $306,220 - $715,350	251,000 New	251,000 $715,000

222

167M

517K

1.61M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $1.01B
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.